Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
PRINCIPAL TECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 0.125 CAD | -16.67% | -16.67% | +19.05% | |
| Sales 2023 | 0.43 0.58 | Sales 2024 * | - | Capitalization | 2.97M 4.04M |
|---|---|---|---|---|---|
| Net income 2023 | -1M -1.36M | Net income 2024 * | - | EV / Sales 2023 | 6 796 312x |
| Net cash position 2023 | 81.08K 110K | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 | -2,36x | P/E ratio 2024 * | Employees | - | |
| Yield 2023 | - | Yield 2024 * |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -16.67% | ||
| 1 week | -16.67% | ||
| Current month | -16.67% | ||
| 1 month | -10.71% | ||
| 6 months | +25.00% | ||
| Current year | +19.05% |
1 week
0.12
0.15
1 month
0.120.15
Current year
0.090.18
1 year
0.090.18
3 years
0.090.25
5 years
0.090.25
10 years
0.090.25
| Managers | Title | Age | Since |
|---|---|---|---|
Gerald Trent
CEO | Chief Executive Officer | 44 | - |
Peter L. McKeown
DFI | Director of Finance/CFO | 67 | Mar. 05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 2021 | |
Leopold Specht
BRD | Director/Board Member | 67 | 2021 |
Gerald Trent
CEO | Chief Executive Officer | 44 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-07 | 0.125 | -16.67% | 20 500 |
| 23-12-06 | 0.15 | 0.00% | 15,000 |
| 23-11-29 | 0.15 | 0.00% | 12,000 |
Delayed Quote Bourse de Toronto, December 07, 2023 at 11:35 am EST
More quotes
Principal Technologies Inc. is a Canada-based company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. It operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The Company's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Calendar
2023-12-12
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +19.05% | 3 M $ | |
| +69.89% | 40 713 M $ | |
| +4.93% | 39 345 M $ | |
| -55.49% | 30 731 M $ | |
| -27.50% | 28 435 M $ | |
| +38.06% | 22 100 M $ | |
| -25.41% | 21 964 M $ | |
| -1.81% | 16 910 M $ | |
| -12.95% | 11 278 M $ | |
| -17.89% | 10 444 M $ |
